Goldman Sachs’s Allergan Inc AGN Stock Holding History

Goldman Sachs’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,479,700	Closed	-$315M	–	7643
2014 Q4	$315M	Buy	1,479,700 +1,037,900	+235%	+$206M	0.1%	210
2014 Q3	$78.7M	Sell	441,800 -358,500	-45%	-$59.5M	0.03%	769
2014 Q2	$135M	Sell	800,300 -146,000	-15%	-$22.7M	0.04%	520
2014 Q1	$117M	Buy	946,300 +654,700	+225%	+$79.7M	0.04%	551
2013 Q4	$32.4M	Buy	291,600 +252,600	+648%	+$24.1M	0.01%	1386
2013 Q3	$3.53M	Sell	39,000 -81,500	-68%	-$7.32M	﹤0.01%	3327
2013 Q2	$10.2M	Buy	+120,500	New	+$12.5M	﹤0.01%	2078

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Goldman Sachs's AGN Position: Q1 2015 in Review

Goldman Sachs sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,321,139 shares — an estimated $281M sold.

Goldman Sachs first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $281M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Goldman Sachs reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Goldman Sachs sold 1,321,139 Allergan Inc shares in Q1 2015, an estimated $281M.
Goldman Sachs first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Goldman Sachs's Allergan Inc position peaked at $281M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.